Filing Details

Accession Number:
0000905148-19-000843
Form Type:
13G Filing
Publication Date:
2019-09-05 17:28:38
Filed By:
Jjbe 123 Llc
Company:
Emmaus Life Sciences Inc. (OTCMKTS:EMMA)
Filing Date:
2019-09-05
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
JJBE 1 0 313,508 0 313,508 313,508 0.66%
ALLAN SCHWEITZER 0 313,508 0 313,508 313,508 0.66%
Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 

 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
 
EMMAUS LIFE SCIENCES, INC.
 (Name of Issuer)
 
Common Stock, par value $0.001 share
 (Title of Class of Securities)
 
29137T101
 (CUSIP Number)
 
July 17, 2019
 (Date of Event which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[    ] Rule 13d-1(b)
 
[ X ] Rule 13d-1(c)
 
[    ] Rule 13d-1(d)
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

Continued on following pages
Page 1 of 8 Pages
Exhibit Index:  Page 7


SCHEDULE 13G
CUSIP No. 29137T101
 
Page 2 of 8 Pages

1
NAMES OF REPORTING PERSONS
 
 
 JJBE 123, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 California
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
 0
 
 
 
 
6
SHARED VOTING POWER
 
 
 313,508
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
 0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
 313,508
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 313,508
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
 0.66%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
 CO
 
 
 
 



SCHEDULE 13G
CUSIP No. 29137T101
 
Page 3 of 8 Pages

1
NAMES OF REPORTING PERSONS
 
 
ALLAN SCHWEITZER
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 United States of America
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
 0
 
 
 
 
6
SHARED VOTING POWER
 
 
 313,508
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
 0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
 313,508
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 313,508
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
 0.66%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
 IN, HC
 
 
 
 





 
Page 4 of 8 Pages

Item 1(a).               Name of Issuer

Emmaus Life Sciences, Inc. (the “Issuer”)

Item 1(b).               Address of Issuer’s Principal Executive Offices

21250 Hawthorne Boulevard, Suite 800, Torrance, California 90503

Item 2(a).               Name of Person Filing

This statement is filed on behalf of the following persons (collectively, the “Reporting Persons”):

i)
JJBE 123, LLC (“JJBE”); and
ii)
Allan Schweitzer (“Mr. Schweitzer”).

This Statement relates to Shares (as defined herein) held by JJBE, a limited liability company engaged in passive investment activities. Mr. Schweitzer is the Manager of JJBE and, in such capacity, may be deemed to be the indirect beneficial owner of all of the Shares directly held by JJBE and reported herein.

Item 2(b).               Address of Principal Business Office or, if None, Residence:

The principal business address of JJBE and Mr. Schweitzer is 1620 26th Street, Suite 6000N, Santa Monica, California 90404.
 
Item 2(c).               Citizenship:

JJBE is a California limited liability company.  Mr. Schweitzer is a citizen of the United States of America.

Item 2(d).               Title of Class of Securities:
 
Common Stock, par value $0.001 per share (the “Shares”)

Item 2(e).               CUSIP Number:

29137T101

Item 3.                    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
                               Check Whether the Person Filing is a:

This Item 3 is not applicable.




 
Page 5 of 8 Pages


Item 4.                    Ownership:
Item 4(a)                Amount Beneficially Owned:

As of the date hereof, each of the Reporting Persons may be deemed the beneficial owner of 313,508 Shares held by JJBE.

Item 4(b)                Percent of Class:

As of the date hereof, each of the Reporting Persons may be deemed the beneficial owner of approximately 0.66% of Shares outstanding. (There were 47,467,152 Shares outstanding as of August 14, 2019, according to the Issuer’s Form 10-Q filed on August 14, 2019).
 
Item 4(c)               Number of Shares as to which such person has:

JJBE AND MR. SCHWEITZER:
(i) Sole power to vote or direct the vote:
                                                   0
(ii) Shared power to vote or direct the vote:
                                       313,508
(iii) Sole power to dispose or direct the disposition of:
0
(iv) Shared power to dispose or direct the disposition of:
313,508
 
Item 5.                   Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

Item 6.                   Ownership of More than Five Percent on Behalf of Another Person:

The Schweitzer 2007 Trust is the sole member of JJBE and, as such, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares held by JJBE.

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company or Control Person:

See disclosure in Item 2 hereof.

Item 8.                    Identification and Classification of Members of the Group:

This Item 8 is not applicable.
 
Item 9.                    Notice of Dissolution of Group:

This Item 9 is not applicable.

Item 10.                 Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.




 
Page 6 of 8 Pages

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


  JJBE 123, LLC
 
       

By:
/s/ Allan Schweitzer
 
    Allan Schweitzer, Manager
 
       

  ALLAN SCHWEITZER
 
       

/s/ Allan Schweitzer
 
   
 
   
 
       
September 5, 2019




 
Page 7 of 8 Pages
 
EXHIBIT INDEX
 
Ex.
 
Page No.
     
A
Joint Filing Agreement
8
     







 
Page 8 of 8 Pages
 
EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Emmaus Life Sciences, Inc. dated as of September 5, 2019 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.


  JJBE 123, LLC
 
       

By:
/s/ Allan Schweitzer
 
    Allan Schweitzer, Manager
 
       

  ALLAN SCHWEITZER
 
       

/s/ Allan Schweitzer
 
   
 
   
 
       
September 5, 2019